Duloxetine versus Placebo in the Treatment of Elderly Patients with Generalized Anxiety Disorder

Update Il y a 4 ans
Reference: EUCTR2009-010902-13

Woman and Man

  • | Country :
  • -
  • | organs :
  • -
  • | Specialty :
  • -

Extract

The primary objective is to assess whether duloxetine 30 to 120 mg once daily is superior to placebo in the treatment of elderly patients (≥65 years old) with Generalized anxiety disorder (GAD).


Inclusion criteria

  • Generalized Anxiety Disorder (GAD)